SEARCH

SEARCH BY CITATION

References

  • Akkoyunlu M & Fikrig E (2000) Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect Immun 68: 18271833.
  • Akkoyunlu M, Malawista SE, Anguita J & Fikrig E (2001) Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis. Infect Immun 69: 55775788.
  • Borjesson DL, Simon SI, Tablin F & Barthold SW (2001) Thrombocytopenia in a mouse model of human granulocytic ehrlichiosis. J Infect Dis 184: 14751479.
  • Bunnel JE, Trigiani ER, Srinivas SR & Dumler JS (1999) Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system. J Infect Dis 180: 546550.
  • Carlyon JA, Akkoyunlu M, Xia L, Yago T, Wang T, Cummings RD, McEver RP & Fikrig E (2003) Murine neutrophils require α1,3-fucosylation but not PSGL-1 for productive infection with Anaplasma phagocytophilum. Blood 102: 33873395.
  • Carlyon JA & Fikrig E (2003) Invasion and survival strategies of Anaplasma phagocytophilum. Cell Microbiol 5: 743754.
  • Choi KS, Garyu J, Park J & Dumler JS (2003) Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin. Infect Immun 71: 45864594.
  • Dumler JS, Choi KS, Garcia-Garcia JC, Barat NS, Scorpio DG, Garyu JW, Grab DJ & Bakken JS (2005) Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Emerg Infect Dis 11: 18281834.
  • Ge Y, Yoshiie K, Kuribayashi F, Lin M & Rikihisa Y (2005) Anaplasma phagocytophilum inhibits human neutrophil apoptosis via up-regulation of bfl-1, maintenance of mitochondrial membrane potential and prevention of caspase 3 activation. Cell Microbiol 7: 2938.
  • Goodman JL, Nelson CM, Klein MB, Hayes SF & Weston BW (1999) Leukocyte infection by the granulocytic ehrlichiosis agent is linked to expression of a selectin ligand. J Clin Invest 103: 407412.
  • Hedrick MN, Olson CM Jr, Conze DB, Bates TC, Rincon M & Anguita J (2006) Control of Borrelia burgdorferi-specific CD4+-T-cell effector function by interleukin-12- and T-cell receptor-induced p38 mitogen-activated protein kinase activity. Infect Immun 74: 57135717.
  • Hodzic E, Ijdo JW, Feng S, Katavolos P, Sun W, Maretzki CH, Fish D, Fikrig E, Telford SR III & Barthold SW (1998) Granulocytic ehrlichiosis in the laboratory mouse. J Infect Dis 177: 737745.
  • Hodzic E, Feng S, Fish D, Leutenegger CM, Freet KJ & Barthold SW (2001) Infection of mice with the agent of human granulocytic ehrlichiosis after different routes of inoculation. J Infect Dis 183: 17811786.
  • Hunter CA (2005) New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5: 521531.
  • Ijdo WJ, Sun W, Zhang Y, Magnarelli LA & Fikrig E (1998) Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response. Infect Immun 66: 32643269.
  • Kang BY, Kim SH, Cho D & Kim TS (2005) Inhibition of interleukin-12 production in mouse macrophages via decreased nuclear factor-kappaB DNA binding activity by myricetin, a naturally occurring flavonoid. Arch Pharm Res 28: 274279.
  • Klein MB, Hu S, Chao CC & Goodman JL (2000) The agent of human granulocytic ehrlichiosis induces the production of myelosuppressing chemokines without induction of proinflammatory cytokines. J Infect Dis 182: 200205.
  • Liu N, Montgomery RR, Barthold SW & Bockenstedt LK (2004) Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect Immun 72: 31953203.
  • Lu HT, Yang DD, Wysk M, Gatti E, Mellman I, Davis RJ & Flavell RA (1999) Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J 18: 18451857.
  • Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, Stewart C, Sarmiento U, Faherty DA & Gately MK (1996) IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4: 471481.
  • Martin ME, Bunnell JE & Dumler JS (2000) Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model. J Infect Dis 181: 374378.
  • Martin ME, Caspersen K & Dumler JS (2001) Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis. Am J Pathol 158: 18811888.
  • Mosmann TT, Cherwinski H, Bond MW, Giedlin MA & Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 23482352.
  • Reneer DV, Kearns SA, Yago T, Sims J, Cummings RD, McEver RP & Carlyon JA (2006) Characterization of a sialic acid- and P-selectin glycoprotein ligand-1-independent adhesin activity in the granulocytotropic bacterium Anaplasma phagocytophilum. Cell Microbiol 8: 19721984.
  • Sun W, IJdo JW, Telford SR III, Hodzic E, Zhang Y, Barthold SW & Fikrig E (1997) Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J Clin Invest 100: 30143018.
  • Telford SRI, Lepore TJ, Snow P, Warner CK & Dawson JE (1995) Human ehrlichiosis in Massachusetts. N Engl J Med 334: 209215.
  • Telford SR III, Dawson JE, Katavolos P, Warner CK, Kolbert CP & Persing DH (1996) Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc Natl Acad Sci USA 93: 62096214.
  • Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nature Rev Immunol 3: 133146.
  • Villarino AV, Huang E & Hunter CA (2004) Understanding the pro- and anti-inflammatory properties of IL-27. J Immunol 173: 715724.
  • Von Loewenich FD, Scorpio DG, Reischl U, Dumler JS & Bogdan C (2004) Control of Anaplasma phagocytophilum, an obligate intracellular pathogen, in the absence of inducible nitric oxide synthase, phagocyte NADPH oxidase, tumor necrosis factor, Toll-like receptor (TLR)2 and TLR4, or the TLR adaptor molecule MyD88. Eur J Immunol 34: 17891797.
  • Walker DH (2005) Ehrlichia under our noses and no one notices. Arch Virol Suppl 19: 147156.
  • Yoshiie K, Kim HY, Mott J & Rikihisa Y (2000) Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect Immun 68: 11251133.